Biodexa Pharmaceuticals (BDRX) Change in Inventory (2015 - 2016)

Biodexa Pharmaceuticals (BDRX) reported Change in Inventory of -$294643.7 for Q4 2016, down 213.17% on a YoY basis from $260356.1 in Q1 2016, and down 213.17% sequentially from -$94084.4 in Q4 2015.

Biodexa Pharmaceuticals (BDRX) Change in Inventory (2015 - 2016) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 2 years of Change in Inventory data on file, last reported at -$294643.7 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Biodexa Pharmaceuticals 18.43 Bn 18.43 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 -294,643.68
Dec 31, 2016 -294,643.68
Dec 31, 2015 -94,084.41
Dec 31, 2015 -94,084.41